Asset
TERIPARATIDE
Entera Bio Ltd. Ordinary Shares
Revenue
No revenue reported in loaded filings.
Clinical trials (2)
| NCT ID | Phase | Status | Start | Completion | Sponsor name | Title |
|---|---|---|---|---|---|---|
| NCT02202603 | phase1 | completed | 2011-07-01 | 2013-08-01 | Entera Bio Ltd. | A Three Stage, Study to Assess the Safety, Pharmacokinetics and Pharmacodynamics of Oral PTH (1-34) in Healthy Subjects |
| NCT05965167 | phase1 | completed | 2023-05-11 | 2026-02-08 | Entera Bio Ltd. | Assess Safety and Compare PK of New Oral hPTH(1-34) Tablet Formulations vs. EBP05 Tablets and Subcutaneous Forteo |
FDA applications (0)
This company has no applications containing this asset.